VANGUARD GROUP INC - PERNIX THERAPEUTICS HLDGS IN ownership

PERNIX THERAPEUTICS HLDGS IN's ticker is PTXTQ and the CUSIP is 71426V306. A total of 33 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q1 2017. The put-call ratio across all filers is 1.15 and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of PERNIX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q4 2018$38,000
-89.5%
90,003
-75.9%
0.00%
Q3 2018$361,000
-60.3%
374,2170.0%0.00%
Q2 2018$909,000
+1.9%
374,217
+0.2%
0.00%
Q1 2018$892,000
+13.5%
373,449
+14.0%
0.00%
Q4 2017$786,000
-23.8%
327,490
+0.0%
0.00%
Q3 2017$1,031,000
-36.2%
327,390
-18.6%
0.00%
Q2 2017$1,617,000
+26.2%
402,423
+16.2%
0.00%
Q1 2017$1,281,000
+158.3%
346,241
+35.5%
0.00%
Q4 2016$496,000255,5590.00%
Other shareholders
PERNIX THERAPEUTICS HLDGS IN shareholders Q1 2017
NameSharesValueWeighting ↓
Aisling Capital LLC 210,000$510,0000.07%
Cetera Investment Advisers 46,750$113,0000.02%
SEARLE & CO. 13,325$32,0000.02%
JACOBS LEVY EQUITY MANAGEMENT, INC 87,643$213,0000.00%
Renaissance Technologies 1,895,000$4,568,0000.00%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 7$00.00%
IFP Advisors, Inc 250$1,0000.00%
Advisor Group, Inc. 177$00.00%
SEI INVESTMENTS CO 5$00.00%
BANK OF AMERICA CORP /DE/ 11$00.00%
View complete list of PERNIX THERAPEUTICS HLDGS IN shareholders